Editorial

newsfeed

We have compiled a pre-selection of editorial content for you, provided by media companies, publishers, stock exchange services and financial blogs. Here you can get a quick overview of the topics that are of public interest at the moment.
360o
Share this page
News from the economy, politics and the financial markets
In this section of our news section we provide you with editorial content from leading publishers.

Latest news

Direct Digital Holdings, Inc. (DRCT) Q4 2024 Earnings Call Transcript

Read More

Q4 GDP Third Estimate: Real GDP At 2.5%, Higher Than Expected

Read More

Unusual Machines, Inc. (UMAC) Q4 2024 Earnings Call Transcript

Read More

Real Brokerage: More Valuable Than I Thought (Rating Upgrade)

Read More

VirTra, Inc. (VTSI) Q4 2024 Earnings Call Transcript

Read More

GeoVax Labs, Inc. (GOVX) Q4 2024 Earnings Call Transcript

Read More

Tracking Cliff Asness' AQR Capital Management 13F Portfolio - Q4 2024 Update

Read More

Abacus Life, Inc. (ABL) Q4 2024 Earnings Conference Call Transcript

Read More

VIG: Index Rebalance Adds Eli Lilly To Bolster Dividend Growth In 2025

Read More

Lantern Pharma Inc. (LTRN) Q4 2024 Earnings Call Transcript

Read More

U.S. Growth Is Slowing, But Recession Risk Still Appears Low

Read More

Spero Therapeutics, Inc. (SPRO) Q4 2024 Earnings Call Transcript

Read More

Clearside Biomedical, Inc. (CLSD) Q4 2024 Earnings Conference Call Transcript

Read More

P3 Health Partners Inc. (PIII) Q4 2024 Earnings Conference Call Transcript

Read More

Sierra Metals Inc. (SMTSF) Q4 2024 Earnings Call Transcript

Read More

Better Choice Company Inc. (BTTR) Q4 2024 Earnings Call Transcript

Read More

Tsakos Energy Navigation Limited (TEN) Q4 2024 Earnings Call Transcript

Read More

INmune Bio, Inc. (INMB) Q4 2024 Earnings Call Transcript

Read More

BioRestorative Therapies, Inc. (BRTX) Q4 2024 Earnings Call Transcript

Read More

Relmada Therapeutics, Inc. (RLMD) Q4 2024 Earnings Call Transcript

Read More

Showing 7561 to 7580 of 7589 entries
DDH honours the copyright of news publishers and, with respect for the intellectual property of the editorial offices, displays only a small part of the news or the published article. The information here serves the purpose of providing a quick and targeted overview of current trends and developments. If you are interested in individual topics, please click on a news item. We will then forward you to the publishing house and the corresponding article.
· Actio recta non erit, nisi recta fuerit voluntas ·